A&AA has spoken with the TGA about EpiPen® and EpiPen®Jr being listed on the TGA website shortages list https://apps.tga.gov.au/Prod/msi/Search/Details/adrenaline-epinephrine

The TGA have confirmed that whilst there is currently sufficient supply of EpiPen® and EpiPen®Jr from Mylan Australia, a change in distribution and constraining of existing supply by Mylan Australia will help people across Australia access EpiPen®/s fairly to help avert an EpiPen® shortage.  

Mylan Australia has said there is no shortage of EpiPen®s in Australia at present. Download PDF of Mylan letter here and letter is shown below.

The only change that has occurred is that instead of pharmacies placing orders through wholesalers, they are now placing them through the Mylan EpiPen Customer Service hotline on 1800 931 625. This change to ordering EpiPen®s is occurring to help with current access of EpiPen®s. As there is an even higher than predicted demand (unlike any other previous demand) which has left some pharmacies struggling to access EpiPen®s from wholesalers, this Mylan controlled ordering system means access will be fair and equal to all Australians no matter where they live. EpiPen®s can still be purchased over the counter but the number of over the counter devices for pharmacies will be evenly shared across the country. There should not be any change to consumer EpiPen access at present. People should be able to access devices both on prescription and off prescription if they are reasonable.

Please share this Mylan notice with your pharmacist if you need to order EpiPen®/s because your device/s has/ have expired or will be expiring in March 2020.